Clinical Trial Update: Almonertinib Plus Microwave Ablation in Advanced Non-small Cell Lung Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating almonertinib in combination with microwave ablation in advanced non-small cell lung cancer is in progress, status currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Almonertinib (almonertinib)

Snippet

Sponsor: Qianfoshan Hospital | Conditions: Advanced Non Small Cell Lung Cancer | Phase 2 | Status: UNKNOWN